CTLA4 is currently viewed as a late-appearing T cell surface receptor which is able to inhibit the proliferation of activated T cells. We sought to identify how CTLA4 ligation exerts these anti-proliferative effects by studying its influence on the activities of the relevant nuclear transcription fa
CTLA-4 and T cell activation
β Scribed by Mariette A Oosterwegel; Rebecca J Greenwald; Didier A Mandelbrot; Robert B Lorsbach; Arlene H Sharpe
- Publisher
- Elsevier Science
- Year
- 1999
- Tongue
- English
- Weight
- 864 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0952-7915
No coin nor oath required. For personal study only.
β¦ Synopsis
The past year has seen significant advances in our understanding of the role of cytotoxic T lymphocyte antigen 4 (CTLA-4) in regulating T cell activation and tolerance. Recent studies indicate that CTLA-4 not only counterbalances CD28 signals but also can inhibit T cell responses independently of CD28. Recent work has also revealed a role for CTLA-4 in regulating Thl /lhP differentiation. Manipulation of CTLA-4 in animal models of autoimmunity has shown that CTlA-4 regulates both the initiation and the progression of autoimmune diseases.
π SIMILAR VOLUMES
T-ccl1 actlvatkm" it was suggested that CTLA-4 may be able to deliver a signal that synergizes with that delivcmd by CD28.